Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer

NCT00002487 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: dipyridamole
DRUG: methotrexate

Sponsor

Ottawa Regional Cancer Centre